Santhera Pharmaceuticals (SPHDF) Q3 2025 Earnings

Sep 23Confirmed
Q2 2024
Q3 2024
Q2 2025
Q3 2025
-3.83
-3.05
-2.28
-1.5

Details

Expected EPS
N/A
Actual EPS
-3.831616
Surprise EPS
N/A
Surprise Percent
N/A

Description

⁨Santhera Pharmaceuticals⁩ (⁦SPHDF⁩) has reported earnings of ⁦-3.831616⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts